Reportstack

Angion Biomedica Corp. - Product Pipeline Review - 2012 New Report

 

Naperville, IL -- (ReleaseWire) -- 09/24/2012 -- Angion Biomedica Corp. - Product Pipeline Review - 2012 provides data on the Angion Biomedica Corp.’s research and development focus. The report includes information on current developmental pipeline, complete with latest updates, and features on discontinued and dormant projects.

Scope

- Angion Biomedica Corp. - Brief Angion Biomedica Corp. overview including business description, key information and facts, and its locations and subsidiaries.
- Review of current pipeline of Angion Biomedica Corp. human therapeutic division.
- Overview of pipeline therapeutics across various therapy areas.
- Coverage of current pipeline molecules in various stages of drug development, including the combination treatment modalities, across the globe.
- Product profiles for late stage and clinical stage products of Angion Biomedica Corp. with complete description of the product’s developmental history, mechanism of action, therapeutic class, target and major milestones.
- Recent updates of the Angion Biomedica Corp.’s pipeline in the last quarter.
- Key discontinued and dormant projects.
- Latest news and deals relating to the products.

Reasons to buy

- Evaluate Angion Biomedica Corp.’s strategic position with total access to detailed information on its product pipeline.
- Assess the growth potential of Angion Biomedica Corp. in its therapy areas of focus.
- Identify new drug targets and therapeutic classes in the Angion Biomedica Corp.’s R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas.
- Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps.
- Exploit collaboration and partnership opportunities with Angion Biomedica Corp..
- Avoid Intellectual Property Rights related issues.
- Explore the dormant and discontinued projects of Angion Biomedica Corp. and identify potential opportunities in those areas.

Keywords

Current R&D Portfolio of Angion Biomedica Corp.; Angion Biomedica Corp. - Key Therapeutics; Angion Biomedica Corp. - Pipeline Overview and Promising Molecules; Angion Biomedica Corp. - News; Angion Biomedica Corp. - Latest Updates; Angion Biomedica Corp. - Pipeline; Angion Biomedica Corp. - Discontinued/Dormant Projects

To view table of contents for this market report please visit:
http://www.reportstack.com/product/89952/angion-biomedica-corp-product-pipeline-review-2012.html